跳至主要内容
临床试验/ACTRN12614000587606
ACTRN12614000587606已完成3 期

Plasma ropivacaine levels and duration of sensory block in women undergoing gynaecological surgery and having ultrasound-guided transversus abdominis blocks with ropivacaine and additives (clonidine and adrenaline) vs ropivacaine alone

Royal Prince Alfred Hospital, Sydney Local Health District0 个研究点目标入组 80 人开始时间: 2014年6月3日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
Female

入选标准

  • Adult female patients, aged 18 to 65, undergoing elective gynaecological surgery and who are planned to receive TAP blocks

排除标准

  • Allergy to any of the drugs in the study, morbid obesity, infection at site of block placement, pre-existing neurological or muscular disease, coagulopathy, significant liver or renal disease, and pregnancy.

研究者

发起方
Royal Prince Alfred Hospital, Sydney Local Health District

相似试验